144 related articles for article (PubMed ID: 30595406)
1. The long noncoding RNA KIAA0125 is upregulated in ameloblastomas.
Diniz MG; França JA; Vilas-Boas FAS; de Souza FTA; Calin GA; Gomez RS; de Sousa SF; Gomes CC
Pathol Res Pract; 2019 Mar; 215(3):466-469. PubMed ID: 30595406
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs expression profile in solid and unicystic ameloblastomas.
Setién-Olarra A; Marichalar-Mendia X; Bediaga NG; Aguirre-Echebarria P; Aguirre-Urizar JM; Mosqueda-Taylor A
PLoS One; 2017; 12(10):e0186841. PubMed ID: 29053755
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation pattern of apoptosis-related genes in ameloblastoma.
Costa S; Pereira NB; Pereira K; Campos K; de Castro WH; Diniz MG; Gomes CC; Gomez RS
Oral Dis; 2017 Sep; 23(6):779-783. PubMed ID: 28248452
[TBL] [Abstract][Full Text] [Related]
5. Rare copy number alterations and copy-neutral loss of heterozygosity revealed in ameloblastomas by high-density whole-genome microarray analysis.
Diniz MG; Duarte AP; Villacis RA; Guimarães BVA; Duarte LCP; Rogatto SR; Gomez RS; Gomes CC
J Oral Pathol Med; 2017 May; 46(5):371-376. PubMed ID: 27682262
[TBL] [Abstract][Full Text] [Related]
6. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.
Salehinejad J; Zare-Mahmoodabadi R; Saghafi S; Jafarian AH; Ghazi N; Rajaei AR; Marouzi P
J Oral Sci; 2011 Jun; 53(2):213-7. PubMed ID: 21712626
[TBL] [Abstract][Full Text] [Related]
8. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
9. Comparative immunohistochemical study of Bcl-X in ameloblastoma, keratocystic odontogenic tumor and adenomatoid odontogenic tumor.
Shukla P; Prabhu S; Jose M; Sripathi Rao BH
J Oral Maxillofac Pathol; 2017; 21(1):51-57. PubMed ID: 28479687
[TBL] [Abstract][Full Text] [Related]
10. Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis.
Chen L; Wang G; Qiao X; Wang X; Liu J; Niu X; Zhong M
Med Sci Monit; 2020 Jan; 26():e921863. PubMed ID: 31990904
[TBL] [Abstract][Full Text] [Related]
11. [Mutation and polymorphism of the ameloblastin gene in ameloblastomas].
Niu CH; Li TJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):678-81. PubMed ID: 17331365
[TBL] [Abstract][Full Text] [Related]
12. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
Kumamoto H; Takahashi N; Ooya K
J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
[TBL] [Abstract][Full Text] [Related]
13. Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor.
Heikinheimo K; Kurppa KJ; Laiho A; Peltonen S; Berdal A; Bouattour A; Ruhin B; Catón J; Thesleff I; Leivo I; Morgan PR
J Dent Res; 2015 Jan; 94(1):101-11. PubMed ID: 25398365
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
Müller S; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
[TBL] [Abstract][Full Text] [Related]
15. Genetic factors in the pathogenesis of ameloblastoma, dentigerous cyst and odontogenic keratocyst.
Ghafouri-Fard S; Atarbashi-Moghadam S; Taheri M
Gene; 2021 Mar; 771():145369. PubMed ID: 33346102
[TBL] [Abstract][Full Text] [Related]
16. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma.
Pereira NB; Pereira KM; Coura BP; Diniz MG; de Castro WH; Gomes CC; Gomez RS
J Oral Pathol Med; 2016 Nov; 45(10):780-785. PubMed ID: 27084044
[TBL] [Abstract][Full Text] [Related]
17. The landscape of genetic alterations in ameloblastomas relates to clinical features.
Gültekin SE; Aziz R; Heydt C; Sengüven B; Zöller J; Safi AF; Kreppel M; Buettner R
Virchows Arch; 2018 May; 472(5):807-814. PubMed ID: 29388014
[TBL] [Abstract][Full Text] [Related]
18. DNA damage response activation and cell cycle dysregulation in infiltrative ameloblastomas: A proposed model for ameloblastoma tumor evolution.
Diniz MG; Guimarães BVA; Pereira NB; de Menezes GHF; Gomes CC; Gomez RS
Exp Mol Pathol; 2017 Jun; 102(3):391-395. PubMed ID: 28454892
[No Abstract] [Full Text] [Related]
19. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125.
Wang YH; Lin CC; Hsu CL; Hung SY; Yao CY; Lee SH; Tsai CH; Hou HA; Chou WC; Tien HF
Ann Hematol; 2021 Feb; 100(2):487-498. PubMed ID: 33225420
[TBL] [Abstract][Full Text] [Related]
20. Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor.
DeVilliers P; Liu H; Suggs C; Simmons D; Daly B; Zhang S; Raubenheimer E; Larsson A; Wright T
Am J Surg Pathol; 2008 Feb; 32(2):256-60. PubMed ID: 18223328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
